Evidence-Based Reviews

Tardive dyskinesia: How to prevent and treat a lingering nemesis

Current Psychiatry. 2003 October;2(10):59-72

References

1. Woerner M, Kane JM, Lieberman JA, et al. The prevalence of tardive dyskinesia, J Clin Psychopharmacology 1991;11:34-42.

2. Caroff SN, Mann SC, Campbell EC, et al. Movement disorders associated with atypical antipsychotic drugs. J Clin Psychiatry 2002;63(suppl 4):12-19.

3. Tollefson GD, Beasley CM, Tran PV, et al. Olanzapine versus haloperidol in the treatment of schizophrenia and schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry 1997;154:457-65.

4. Jeste DV, Lacro JP, Bailey A, et al. Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J Am Geriatr Soc 1999;47:716-19.

5. Kumet R, Freeman MP. Clozapine and tardive dyskinesia. J Clin Psychiatry 2002;63:167-8.

6. Hong KS, Cheong SS, Woo J-M, Kim E. Risperidone-induced tardive dyskinesia. Am J Psychiatry 1999;156:1290.-

7. Ghaemi SN, Ko JY. Quetiapine-related tardive dyskinesia. Am J Psychiatry 2001;158:1737.-

8. Kane JM. Tardive dyskinesia: epidemiological and clinical presentation. In: Bloom FE, Kupfer DJ (eds.) Psychopharmacology: The fourth generation of progress. New York: Raven Press, Ltd, 1995;1485-95.

9. Guy W. ECDEU assessment manual for psychopharmacology (rev. ed). Washington, DC: Department of Health, Education and Welfare, 1976.

10. Madhusoodanan S, Brenner R. Reversible choreiform dyskinesia and extrapyramidal symptoms associated with sertraline therapy. J Clin Psychopharmacology 1997;17:138-9.

11. Glazer WM, Morgenstern H, Pultz JA, et al. Incidence of tardive dyskinesia is lower with quetiapine treatment than with typical antipsychotics in patients with schizophrenia and schizo-affective disorder. Schizophrenia Res 2000;41:206-7.

12. Hirsch SR, Kissling W, Bauml J, et al. A 28-week comparison of ziprasidone and haloperidol in outpatients with stable schizophrenia. J Clin Psychiatry 2002;63:516-23.

13. Kujawa M, Sala A, Ingenito GG, et al. Aripiprazole for long-term maintenance treatment of schizophrenia (poster presentation). Montreal, Canada: Collegium Internationale Neuropsychopharmacologicum 23rd congress, June 23-27, 2002.

14. Gupta S, Mosnik D, Black DW, et al. Tardive dyskinesia: review of treatments past, present and future. Ann Clin Psychiatry 1999;11:257-66.

15. Suzuki E, Obata M, Yoshida Y, Miyaoka H. Tardive dyskinesia with risperidone and anticholinergics. Am J Psychiatry 2002;159:1948.-

16. Nasrallah HA. A review of the effect of atypical antipsychotics on weight. Psychoneuroendocrinology 2003;28(suppl 1):83-96.

17. Gardos G, Casey DE, Cole JO, et al. Ten-year outcome of tardive dyskinesia. Am J Psychiatry 1994;151:836-41.

18. Lieberman JA, Saltz BL, Johns CA, et al. The effects of clozapine on tardive dyskinesia. Br J Psychiatry 1991;158:503-10.

19. Tamminga CA, Thaker GK, Moran M, et al. Clozapine in tardive dyskinesia: observations from human and animal model studies J Clin Psychiatry 1994;55(suppl B):102-6.

20. Leucht S, Wahlbeck C, Hermann J, Kissling W. New-generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Lancet 2003;361:1581-9.

21. Adler LA, Rotrosen J, Edson R, et al. Vitamin E treatment of tardive dyskinesia. Arch Gen Psychiatry 1999;56:836-41.

22. Shamir E, Barak Y, Shalman I, et al. Melatonin treatment for tardive dyskinesia. Arch Gen Psychiatry 2001;58:1046-52.

23. Glazer WM, Woods SW. Should Sisyphus have taken melatonin? Arch Gen Psychiatry 2001;58:1054-5.

24. Richardson MA, Bevans M, Read LL, et al. Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men. Am J Psychiatry 2003;160:1117-24.

25. Gardos G, Cole JO. The evaluation and treatment of neurolepticinduced movement disorders. Harvard Rev Psychiatry 1995;3:130-9.

26. Lohr JB, Caligiuri MP, Edson R, et al. Treatment predictors of extrapyramidal side effects in patients with tardive dyskinesia: results from Veterans Affairs Cooperative Study 394. J Clin Psychopharmacol 2002;22:196-200.

27. Casey DE. Effect of clozapine therapy in schizophrenic individuals at risk for tardive dyskinesia. J Clin Psychiatry 1998;59(suppl 3):31-7.